Somatrem
(Redirected from Protropin)
 | This article needs additional citations for verification. (June 2019) |
| Clinical data | |
|---|---|
| Trade names | Protropin |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| ATC code | |
| Identifiers | |
| CAS Number | |
| DrugBank | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| ChEMBL | |
| E number | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C995H1537N263O301S8 |
| Molar mass | 22256.26 g·mol−1 |
| ☒check (what is this?) (verify) | |
Somatrem, sold under the brand name Protropin, is an analogue of growth hormone (GH).[1]
Overview
[edit | edit source]Somatrem is a recombinant human growth hormone used for the treatment of short stature due to decreased or absent secretion of endogenous growth hormone.
Somatrem was first marketed under the brand name Protropin by Genentech in 1985.[2] It differs from endogenous growth hormone by the addition of an extra methionine at the N-terminus[3][circular reference].
Somatrem has largely been replaced by somatropin, marketed by several companies including by Genentech as the brand Nutropin.
References
[edit | edit source]- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Growth hormone therapy#cite note-32
External links
[edit | edit source]- Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- HyperGH 14x Growth Hormone Info.
Lua error in mw.title.lua at line 392: bad argument #2 to 'title.new' (unrecognized namespace name 'Portal').
